Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaccine Preclinical Toxicity Study Workshop Will Address Dosing And Design

Executive Summary

A workshop by FDA's Center for Biologics Evaluation & Research on preventative vaccine development Dec. 2-3 will consider the maximum dose for animal toxicology studies
Advertisement

Related Content

Vaccine Toxicity Studies Could Use Earlier FDA Input, Reviewer Suggests
Vaccine Toxicity Studies Could Use Earlier FDA Input, Reviewer Suggests
Preventive vaccines workshop
Vaccine Preclinical Toxicity Study Guidance Under Development
Advertisement
UsernamePublicRestriction

Register

PS040668

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel